The QualityStocks Daily Stock List
- Know Labs, Inc. (KNWN)
- Prophecy Development Corp. (PRPCF)
- Repro Med Systems, Inc. (REPR)
- Sun Pacific Holding Corp. (SNPW)
- Texas Mineral Resources Corp. (TMRC)
- MYnd Analytics, Inc. (MYND)
- Nu-Med Plus, Inc. (NUMD)
- Nutriband, Inc. (NTRB)
- Liberty One Lithium Corp. (LRTTF)
- Lixte Biotechnology Holdings, Inc. (LIXT)
- MRI Interventions, Inc. (MRIC)
- Teranga Gold Corporation (TGCDF)
- Organigram Holdings, Inc. (OGRMF)
- CanAlaska Uranium Ltd. (CVVUF)
Know Labs, Inc. (KNWN)
Amigo Bulls, Business Wire, 4-Traders, YCharts, Open Insider, Marketbeat, last10k, Stockwatch, VentureLine, MarketWatch, Simply Wall St, Stockopedia, Investors Hangout, TradingView, High Rising Stocks, Dividend Investor, OTC Markets, Spotlight Growth, Insider Tracking, Stockhouse, Insider Monkey, InvestorsHub, Street Insider, and Wallet Investor reported earlier on Know Labs, Inc. (KNWN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Know Labs, Inc. is developing a new technology platform that measures blood glucose non-invasively. The OTCQB-listed Company invented a pioneering technology called Bio-RFID that will provide information to consumers about their health and wellness. Additionally, Know Labs utilizes its proprietary ChromaID technology to identify unique molecular signatures in materials. The Company previously went by the name Visualant, Incorporated. It changed its name to Know Labs, Inc. in May 2018. Know Labs has its corporate headquarters in Seattle, Washington.
The Company develops technology platforms that harness light and radio waves to uncover distinct insights about the world. Its technology directs electromagnetic energy through a substance or material to capture a unique molecular signature. Know Labs refers to these signatures as ChromaID™ and Bio-RFID™. ChromaID and Bio- RFID are used to identify, detect, or diagnose substance markers or biomarkers that may be invisible to the human eye.
ChromaID and Bio-RFID scanner modules can be integrated into an array of mobile or bench-top form factors. This patented and patent pending, award-winning technology makes it possible to effectively conduct analyses that could only previously be performed by invasive and/or large and expensive lab-based tests.
Know Labs announced in August 2018 its UBAND™ real time wearable calorie counter wrist band. The Calorie Counter UBAND is built upon the Company’s recent invention that detects blood glucose non-invasively. At present, Know Labs has 12 issued patents with 20 pending, covering its specialty.
Last month, Know Labs released a video highlighting its product pathway and platform. In the video, Chief Executive Officer, Mr. Phil Bosua, discusses the Company’s Bio-RFID™ technological breakthrough and the plans for bringing the technology to market.
The transcript of Mr. Bosua’s narrative in the video states in part, “We originally set out to detect blood glucose and in turn, created a platform. We’ve begun initial research to measure all types of substances in the blood and interstitial fluid. Biomarkers like cortisol for stress levels, as well as continuous measurement of the luteinizing hormone, which would indicate ovulation within the next 4 hours – ideal for those wanting to get pregnant. We’re now ahead of schedule and look forward to creating the future of non-invasive health measurements.”
Know Labs, Inc. (KNWN), closed Wednesday's trading session at $1.4225, up 3.08%, on 30,630 volume with 49 trades. The average volume for the last 3 months is 57,596 and the stock's 52-week low/high is $0.231/$5.75.
Prophecy Development Corp. (PRPCF)
InvestorIntel, Marketwired, Wallmine, GuruFocus, Wallet Investor, Junior Mining Network, OTC Markets, Stockhouse, The StreetWise Reports, Barchart, 4-Traders, InvestorsHub, Business Wire, Uptick Newswire, and TradingView reported earlier on Prophecy Development Corp. (PRPCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Prophecy Development Corp. engages in the acquisition, exploration, and development of mineral and energy projects. Its main goal is to develop the Gibellini primary vanadium mining project in the Battle Mountain area in northeastern Nevada to production. The design of the Gibellini vanadium project is to be an open pit, heap leach operation. OTCQX-listed, Prophecy Development is headquartered in Vancouver, British Columbia.
In June of 2018, Prophecy Development announced the filing of a technical report prepared in accordance with National Instrument 43-101, Standards of Disclosure for Mineral Projects (NI 43-101) regarding a Preliminary Economic Assessment (PEA) for the Company’s Gibellini vanadium project in Eureka, Nevada. The project is roughly 25 miles south of the town of Eureka.
The PEA reported an after-tax cumulative cash flow of $601.5 million, an Internal Rate of Return (IRR) of 50.8 percent, a Net Present Value (NPV) of $338.3 million at a 7 percent discount rate and a 1.72 years payback on investment from start-up assuming an average vanadium pentoxide price (V2O5) of $12.73 per pound.
Prophecy Development also has its Pulacayo (Silver-Zinc-Lead) project. This Project is in Bolivia, 107 km northeast of Sumitomo Corporation’s San Cristobal silver mine; 185 km southwest of Coeur Mining, Inc.’s San Bartolome silver mine; and 139 km north of Pan American Silver Corp.’s San Vicente silver mine.
In addition, the Company has its Titan (Titanium Vanadium) Project. This Project is at Flett and Angus Townships, 120 kilometers northeast of Sudbury, Ontario. The Property consists of 262 contiguous hectares consisting of 17 patented claims.
Prophecy Development announced in October 2018 that it executed a lease agreement with an arms-length private Mongolian company. The Lessee plans to perform mining operations at Prophecy's Ulaan Ovoo coal mine. It will pay Prophecy US$2 (Production Royalty) for every tonne of coal shipped from the Ulaan Ovoo site premises. Ulaan Ovoo has nameplate production capacity of 2 million tonnes annually.
Last month, Prophecy Development announced that it selected M3 Engineering & Technology Corporation (M3) of Tucson, Arizona to provide engineering, procurement, construction and management services (EPCM) for its Gibellini Vanadium Project in response to its Request for Proposal. M3 was chosen for its particular experience in heap leach engineering, and construction expertise in arid environments such as Nevada and Arizona.
Prophecy Development Corp. (PRPCF), closed Wednesday's trading session at $0.17, up 5.52%, on 192,052 volume with 49 trades. The average volume for the last 3 months is 124,500 and the stock's 52-week low/high is $0.086/$2.75.
Repro Med Systems, Inc. (REPR)
Zacks, Marketbeat, Business Wire, Simply Wall St, Stockhouse, 4-Traders, Market Exclusive, Streetwise Reports, Equity Clock, Street Insider, and Stock News Times reported on Repro Med Systems, Inc. (REPR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Repro Med Systems, Inc. (d/b/a RMS Medical Products) develops, manufactures and commercializes medical products used for home infusions and suctioning. The Company is a leading developer and manufacturer of medical devices and supplies. It centers on designing and manufacturing safe, affordable medical devices to make quality healthcare a reality for all. Repro Med Systems is based in Chester, New York. The Company lists on the OTC Markets Group’s OTCQX.
Repro Med Systems’ products and product support are provided worldwide by RMS and through a global network of distributors and service providers.
The Company’s principal products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™, and RES-Q-VAC® Hand Held Medical Suction.
The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional healthcare settings and also at home. Repro Med's RES-Q-VAC® line of medical suctioning products are used by emergency medical service providers in addition to a variety of other healthcare providers.
Repro Med Systems specializes in developing and manufacturing portable medical devices and supplies for a wide array of markets. These markets include hospitals, home healthcare, nursing homes, and rescue services. The Company’s products do not rely on batteries or electric power. As a result, this makes them dependable in critical situations.
Recently, Repro Med Systems announced financial results for Q3 ended September 30, 2018. Net Sales increased to $4.5 million. This represents an 18.1 percent increase over Q3 of 2017. The increase in Net Sales was driven by market expansion and gains in needle sets, tubing and pump sales.
Gross Profit increased to $2.9 million, or 63.6 percent of Net Sales. This represents a 21.6 percent increase over Q3 2017 Gross Profit of $2.4 million, or 61.8 percent of Net Sales. The increase in Gross Profit was primarily driven by the increase in Net Sales as well as operating efficiencies.
Net Income for the period increased to $386,553, or 8.5 percent of Net Sales. This represents an increase of 45 percent versus $265,754, or 6.9 percent of Net Sales, reported during Q3 of 2017.
Repro Med Systems, Inc. (REPR), closed Wednesday's trading session at $1.57, up 1.95%, on 5,300 volume with 7 trades. The average volume for the last 3 months is 21,969 and the stock's 52-week low/high is $1.10/$1.79.
Sun Pacific Holding Corp. (SNPW)
MarketWatch, Marketwired, Zacks, 4-Traders, and Investorx reported previously on Sun Pacific Holding Corp. (SNPW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sun Pacific Holding Corp., by way of its subsidiaries, provides solar bus stops, solar trashcans and “street kiosks” using its innovative advertising offerings that provide state and local municipalities with cost efficient solutions. The Company’s subsidiaries include Sun Pacific Power Corp., Street Smart Outdoor Corp., Sun Pacific Security Corp., and National Mechanical Group. A green energy, OTCQB-listed company, Sun Pacific is based in Manalapan, New Jersey.
Sun Pacific specializes in solar and waste to energy technologies. Subsidiary Sun Pacific Security will offer customers the latest in security automation systems. This subsidiary enables one to view secure, live and recorded video of their property at any time on their computer, smartphone or tablet. Sun Pacific Security has not commenced operations in the security sector. It is reviewing plans to provide customers the latest in security automation systems.
Subsidiary Sun Pacific Power builds next generation solar panels and lighting products made primarily in the United States. Sun Pacific Power has eight global manufacturing and assembly locations. These include five in the U.S.
Sun Pacific Power provides solar powered bus shelters, solar powered LED trash bins, solar products and lighting products. The Smart Solar Bus Shelter provides LED lighting for increased visibility and security and other technological additions not previously available.
Street Smart Outdoor is Sun Pacific’s street furniture outdoor advertising subsidiary. Currently, it is maintaining advertising space on greater than 1,000 bus shelter faces, bus benches, smart solar digital shelters and solar trash bins.
Sun Pacific is integrating blockchain technology into its renewable energy business model and strategy designed to improve grid management efficiency for solar and wind farms. The Company earlier signed a Letter of Intent (LOI) to buy 60 acres of land to build a solar and wind farm, where electricity generation will be optimized via a combination of both energy sources. The Company plans to take the project one step closer to the future through using blockchain technology to monitor the new grid, load balance, and increase the life of electrical equipment.
Sun Pacific Holding Corp. (SNPW), closed Wednesday's trading session at $0.00402, up 3.08%, on 80,000 volume with 2 trades. The average volume for the last 3 months is 1,844,217 and the stock's 52-week low/high is $0.0032/$0.25.
Texas Mineral Resources Corp. (TMRC)
Stockrow, InvestorsHub, OTC Markets, Marketwired, Stock Digest, and TradingView reported earlier on Texas Mineral Resources Corp. (TMRC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Texas Mineral Resources Corp. is an exploration company listed on the OTC Markets’ OTCQB. It is targeting the heavy rare earths and a variety of other high-value elements and industrial minerals. Its focus is exploring and, if warranted, developing its Round Top heavy rare earth and industrial minerals project in Hudspeth County, Texas, 85 miles east of El Paso. Texas Mineral Resources has its corporate office in Sierra Blanca, Texas.
In 2017, the Company added a new strategic line of business with the creation of a subsidiary called American Mineral Reclamation LLC. The formation of this subsidiary is in response to the increasing number of opportunities that the Company was presented because of work undertaken with partners that resulted in winning grants from the Department of Defense (Defense Logistics Agency) and the Department of Energy.
Additionally, Texas Mineral Resources’ plan is to develop alternative sources of strategic minerals through the processing of coal waste and other related materials. The Company’s flagship property, Round Top Mountain, is near Sierra Blanca in Hudspeth County.
Round Top is one of four principal rhyolite bodies, an igneous volcanic rock, making up the group of mountains called The Sierra Blanca. The Preliminary Economic Assessment (PEA) was completed based on the measured, indicated and inferred Resource Estimate Technical Report filed on December 20, 2013 by Texas Rare Earth Resources.
The resource incorporated into the current mine plan totals 525.4 million kg of rare earth oxide (REO), with an average grade of 634 ppm total rare earth oxides (TREO). Of the TREO, roughly 72 percent comprise heavy rare earth oxides plus Yttrium. The Company holds 19-year renewable leases from the State of Texas on 950 acres encompassing Round Top and additional prospecting permits on adjacent areas encompassing an additional 9,345 acres.
Last month, Texas Mineral Resources announced that it reached a development and funding agreement for its Round Top project with Morzev Pty Ltd., d/b/a USA Rare Earth, a privately-held U.S. and Australian-based investment group. With this Agreement, USA Rare Earth is required to spend up to $10 million by way of two tranches. The first $2.5 million is to finish the optimization of the separation and purification processes relating to the different elements contained in the deposit. Upon successful conclusion, USA Rare Earth is subsequently required to spend up to an additional $7.5 million to produce a bankable Feasibility Study (FS).
Texas Mineral Resources Corp. (TMRC), closed Wednesday's trading session at $0.195, up 2.63%, on 69,320 volume with 14 trades. The average volume for the last 3 months is 14,351 and the stock's 52-week low/high is $0.101/$0.349.
MYnd Analytics, Inc. (MYND)
Stock Twits, Simply Wall St, 4-Traders, Barchart, Talk Traders, OTC Markets, The Street, Business Insider, Bzweekly, Zacks, Equity Clock, Capital Cube, BioSpace, MarketWatch, Marketbeat, GuruFocus and Street Insider reported previously on MYnd Analytics, Inc. (MYND), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
MYnd Analytics, Inc. is a market leader in reducing costs and improving the delivery of mental health services through the combination of telemedicine and data analytics/artificial (augmented) intelligence. MYnd brings objective physical findings to psychiatric treatment to reduce trial and error treatment in mental health. The Company provides an innovative set of reference data and analytic tools for clinicians and researchers in psychiatry. A predictive medicine company, MYnd Analytics is based in Mission Viejo, California.
MYnd Analytics continues to integrate its earlier acquired Arcadian Telepsychiatry Services LLC business into its legacy business. MYnd Analytics earlier announced that its wholly-owned subsidiary, Arcadian Telepsychiatry Services launched a new program to offer, via its network of Providers, youths in rural, suburban and urban markets with school-based access to telepsychiatry, teletherapy and other mental health services.
Telepsychiatry involves the use of video conferencing equipment to conduct real time mental health consultations between a clinician and a patient. The design of the program is to benefit children and teenagers throughout the nation, especially those with limited access to mental health services.
MYnd has its Psychiatric EEG Evaluation Registry, or PEER Online®. The aim of PEER Online is to provide objective, personalized data to help physicians in the selection of suitable medications. PEER Online is a cloud-based platform. It is a registry and reporting platform. PEER Online enables medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG).
PEER combines a "crowdsourced" secure physician outcome registry with electroencephalogram (EEG). EEG is an accepted, well-normed test of brain function. EEG is a completely painless, non-invasive test that records one’s brain’s electrical activity.
The Company also has its MYnd Analytics Center. The Center provides a convenient, relaxing, and welcoming environment for one to receive their EEG and PEER Report™. The EEG is performed on-site at the MYnd Analytics Center. Physicians who use PEER lessen trial and error re-scribing.
Recently, MYnd Analytics announced that it was awarded a subcontract to incorporate its PEER report within a project to develop a suicide prevention toolkit, for the U.S. Department of Health and Human Services (HHS).
Mr. George Carpenter, Chief Executive Officer of MYnd Analytics, stated, “We are honored to be a part of this important project, which involves development of a suicide prevention tool kit for HHS. Importantly, we look forward to leveraging our expertise and the extensive data we have compiled through the PEER registry... Multiple studies — including two of our own — have shown a relationship between EEG findings, medication response, and suicidality. We look forward to leveraging this powerful data as part of this new HHS sponsored program.”
MYnd Analytics, Inc. (MYND), closed Wednesday's trading session at $1.35, up 0.75%, on 171,521 volume with 457 trades. The average volume for the last 3 months is 225,812 and the stock's 52-week low/high is $0.62/$4.079.
Nu-Med Plus, Inc. (NUMD)
Stockhouse, Wallet Investor, OTC Markets, Marketwired, Investing News, Street Insider, The StreetWise Reports, MarketWatch, The Street, Venture Line, Stockopedia, Business Insider, Morningstar, GuruFocus, Capital Cube, last10k, TradingView, Wallmine, and Stockwatch reported earlier on Nu-Med Plus, Inc. (NUMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Nu-Med Plus, Inc. investigates and develops applications of Nitric Oxide technologies in the medical field. The OTCQB-listed Company formed to explore medical applications of newly developed technologies. Its strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. A medical device business, the Company is headquartered in Salt Lake City, Utah.
Inhaled Nitric Oxide (INO) is a medically essential gas. It is currently used in Neonate Hypoxia therapy (inadequate oxygen level in newborns), COPD and other pulmonary problems. Nu-Med Plus has the capability to deliver high purity Inhaled Nitric Oxide (INO) to the patient at point of use. INO may have future applications for an assortment of other diseases and medical complications that are now being investigated.
Nu-Med’s markets include neonatal complications, COPD, Tuberculosis, Malaria, and ARDS (a severe lung syndrome with no known cure). The Company’s team has developed a new Nitric Oxide (NO) gas delivery system. This system provides a continuous intra-breath concentration of therapeutic NO to medically supervised patients who are on ventilators in a hospital setting.
Last week, Nu-Med Plus announced it will receive its first clinical unit prototype and commence testing to verify design parameters. The design of the Nu-Med Plus clinical unit is to provide clinicians and care providers a number of key competitive advantages. The small unit fits easily into medical offices, emergency departments, as well as nursing homes. The unit offers a touch screen for ease-of-use and precision single-dose control. The clinical unit uses either a proprietary formula of nitric oxide generation or prefilled nitric oxide canisters.
Mr. Jeff Robins, Chief Executive Officer of Nu-Med Plus, stated, “The clinical unit multiplies the number of markets Nu-Med Plus is able to serve with our technology. The market-leading innovation offers providers and patients new treatment options, in new convenient environments, to address health issues that significantly impact quality of life and cost billions of dollars annually to treat.”
Nu-Med Plus, Inc. (NUMD), closed Wednesday's trading session at $0.99, up 16.75%, on 500 volume with 1 trade. The average volume for the last 3 months is 657 and the stock's 52-week low/high is $0.449/$1.009.
Nutriband, Inc. (NTRB)
Market News Updates, Penny Stock Hub, Morningstar, Insider Monkey, Simply Wall St, GuruFocus, Barchart, InsiderMole, 4-Traders, The Street, Stockopedia, OTC Markets, MarketWatch, InvestorsHub, Stockhouse, last10k, Market Screener, and Stockwatch reported previously on Nutriband, Inc. (NTRB), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Nutriband, Inc. is a health and pharmaceutical Company listed on the OTC Markets Group’s OTCQB. The basis of all its products is around the science of Transdermal /Topical technologies. Nutriband Life Sciences is the pharmaceutical division of Nutriband, Inc. A Nevada corporation, Nutriband has its corporate office in Orlando, Florida.
The design of Nutriband’s products is on the principle that molecular combinations can be absorbed not only orally but also via the skin. Because of the intake method, all of the Company’s products contain nothing but the bare essential ingredients. This is because there is no need for binders, fillers or unwanted animal by-products such as gelatine.
The Nutriband Life Sciences division concentrates on the development, research and marketing of unique drug delivery systems. At present, its drug pipeline is in formulation, feasibility, and pre-clinical evaluation.
Last year, Nutriband acquired 4P Therapeutics, Inc. 4P Therapeutics becomes the Pharmaceutical and Development arm of Nutriband. 4P Therapeutics has a specific emphasis on Transdermal and Topical Technologies, prescription drugs, as well as clinical development.
Included in the acquisition of 4P Therapeutics’ Intellectual Property (IP) Portfolio is Defent™ abuse deterrent patch technology. This is an opioid abuse deterrent platform. It is for the transdermal delivery of opioid-based medications. Defent™ reduces the risk of abuse and misuse, creating a safer treatment for patients.
In September of 2018, Nutriband signed the definitive acquisition agreement to acquire Carmel Biosciences, Inc. According to this deal, Nutriband acquires the NDA and ownership rights to Food and Drug Administration (FDA) approved Prexxartan™, the ownership and rights to develop and market Carmel's pipeline including CAR-509, CAR-510, CAR-511 and CAR-512 now in Pre IND phase, and rights to Carmel's clinically tested nutraceutical line.
Recently, Nutriband announced that the United States Patent and Trademark Office (USPTO) granted the Company's request for Prioritized Examination (Track One) of the U.S. patent application for "Abuse and Misuse Deterrent Transdermal System" submitted by its subsidiary, 4P Therapeutics LLC.
Track One gives Nutriband's application special status with fewer requirements than the present accelerated examination program and without having to perform a pre-examination search. Nonetheless, the application still needs to be reviewed by the USPTO. Moreover, the grant of Track One status does not mean that a patent will be granted.
Nutriband, Inc. (NTRB), closed Wednesday's trading session at $10.05, up 0.40%, on 1,999 volume with 6 trades. The average volume for the last 3 months is 620 and the stock's 52-week low/high is $4.01/$12.69.
Liberty One Lithium Corp. (LRTTF)
Procative Investors, Investors Hangout, OTC Markets, 4 Traders, Geology for Investors, Stock Digest, Private Capital Newswire, and MarketWatch reported earlier on Liberty One Lithium Corp. (LRTTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Liberty One Lithium Corp. is a developing exploration company that concentrates on the acquisition and development of high grade lithium brine deposits. The Company sees lithium as an opportunity to participate in the diversification and continued growth (and protection) of a strong international energy policy. The Company previously went by the name Peace River Capital Corp. It changed its name to Liberty One Lithium Corp. in December 2016. The Company is headquartered in Vancouver, British Columbia.
Liberty One Lithium’s initial prospects are in Argentina’s “Lithium Triangle” and Utah’s Paradox Basin. They are in historic sources of high grade lithium-bearing brines. Historic resource indicates potential to produce huge volumes of brine on-site.
In Argentina, Liberty One Lithium’s Pocitos West prospect comprises greater than 39,000 acres (15,857 Ha) in the middle of the well-known lithium triangle. It is in the Pocitos Salar, Los Andes Department, Western Salta Province, Argentina. The Project is in the middle of all the current lithium Projects of the region.
In Utah, the Company’s North Paradox property comprises 233 placer claims covering 4,480 acres situated upon the Paradox Basin in Grand County, Utah, 15 kilometers west of the town of Moab, in southeastern Utah. Liberty One Lithium has a mineral option and joint venture (JV) agreement with Millennial Lithium Corp. (Vancouver, British Columbia). This agreement grants Liberty One Lithium the sole and exclusive right and option to acquire up to an 80 percent undivided beneficial right, title, and interest in the Pocitos West project in Argentina.
This past August, Liberty One Lithium announced the appointment of Mr. Nathan Steinke, CPA, CA to the position of Chief Financial Officer of the Company. Mr. Steinke is a highly respected financial professional. He has more than15 years of experience leading the finance functions for public and private companies in the global resource sector.
Since 2003, Mr. Steinke’s responsibilities have consisted of all financial aspects of the companies. This includes debt and equity financings, corporate structure design and management, cash flow management and forecasting, legal and regulatory compliance, stakeholder engagement and reporting, dual listing execution and management, and risk management.
Liberty One Lithium Corp. (LRTTF), closed Wednesday's trading session at $0.082, down 1.80%, on 11,620 volume with 10 trades. The average volume for the last 3 months is 67,118 and the stock's 52-week low/high is $0.043/$0.378.
Lixte Biotechnology Holdings, Inc. (LIXT)
Spotlight Growth, Real Pennies, Proactive Investors, Penny Stock Hub, YCharts, Stockhouse, 4-Traders, MarketWatch, InvestorsHub, and Simply Wall St reported earlier on Lixte Biotechnology Holdings, Inc. (LIXT), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Lixte Biotechnology Holdings, Inc. is a drug discovery company listed on the OTCQB. The Company utilizes biomarker technology to identify enzyme targets associated with serious common diseases and subsequently designs novel compounds to attack those targets. Lixte’s product pipeline covers two major categories of compounds at varied stages of pre-clinical and clinical development that the Company believes have wide-ranging therapeutic potential for cancer and other debilitating and life-threatening diseases. A clinical-stage company, Lixte Biotechnology has its corporate office in East Setauket, New York.
Lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. Its cancer drug development strategy has led to the discovery of novel compounds. The deacetylase inhibitors are in pre-clinical development for the prevention and treatment of neurodegenerative diseases, traumatic brain injury, and topically for fungal dermatitis. The phosphatase inhibitors are in pre-clinical development for reducing the extent of tissue damage following stroke, heart attack, and septic shock.
At present, the Company’s drug portfolio includes inhibitors of serine/threonine protein phosphatases that are crucial to cell division. Lixte’s portfolio also includes DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.
Lixte’s unique phosphatase inhibitor is LB-100, its lead compound. LB-100 is in a Phase I clinical trial at two NCI designated Comprehensive Cancer Centers and three U.S. Oncology Research locations. The Company granted an exclusive license of its LB-100 for the treatment of hepatocellular carcinoma (HCC) in Asia to Taipei Medical University (TMU). Currently, LB-100 is not approved for treatment of HCC.
Lixte Biotechnology announced this past October that it submitted an IND to the Food and Drug Administration (FDA) to conduct a Phase 1b/2 trial of the safety and therapeutic benefit of lead clinical compound, LB-100, in patients with low and intermediate-1 risk myelodysplastic syndrome (MDS) who have failed or are intolerant of standard treatment. The study will take place at Moffitt Cancer Center, Tampa, Florida.
In November, Lixte Biotechnology announced that the FDA approved its IND to conduct a Phase 1b/2 trial of the safety and therapeutic benefit of the Company’s lead clinical compound, LB-100, in patients with low and intermediate-1 risk myelodysplastic syndrome (MDS) who have failed or are intolerant of standard treatment.
Lixte Biotechnology Holdings, Inc. (LIXT), closed Wednesday's trading session at $0.94, up 4.44%, on 2,600 volume with 3 trades. The stock's 52-week low/high is $0.125/$1.84.
MRI Interventions, Inc. (MRIC)
NetworkNewsWire, Investing Note, FeedBlitz, Insider Financial, Earnings Cast, Stockhouse, Dividend Investor, Wallmine, Capital Cube, Market Exclusive, Wall Street Resources, InvestorsHub, Real Pennies, Stockhouse, and 4-Traders reported previously on MRI Interventions, Inc. (MRIC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
MRI Interventions, Inc. is a commercial stage medical device company based in Irvine, California. It develops and commercializes distinct platforms for performing minimally invasive surgical procedures in the brain under direct, intra-procedural Magnetic Resonance Imaging, or MRI, guidance. Using a hospital's existing MRI suite, the design of its Food and Drug Administration (FDA)-cleared and CE-marked ClearPoint® system is to enable a range of minimally invasive procedures in the brain.
The Company’s focus is Magnetic Resonance Imaging (MRI)-Guided Neurosurgical procedures. The ClearPoint® system enables real-time MRI-guided navigation for a broad variety of minimally-invasive neurosurgery procedures. The ClearPoint® system is the only navigation platform designed to allow real-time visualization during minimally-invasive neurosurgical procedures. The platform is especially well-matched for facilitating drug delivery directly to brain tumors.
The ClearPoint® system provides MRI-based stereotactic guidance for the placement and operation of instruments or devices during the planning and operation of neurological procedures performed within the MRI suite. ClearPoint® procedures can be used with 1.5T and 3T scanners.
MRI Interventions has a co-development and co-distribution agreement with Brainlab regarding the ClearPoint® system. Brainlab is a leader in software-driven medical technology. In addition, MRI Interventions is developing the ClearTrace® system in partnership with Siemens Healthcare. This is to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.
Earlier this month, MRI Interventions announced participation in the RESTORE-1 gene therapy trial for Parkinson’s disease sponsored by Voyager Therapeutics. With this agreement with Voyager, MRI Interventions provided the navigation system and drug infusion cannulae, and also clinical support during the procedure to assist the Voyager team in executing the clinical protocol.
The Phase 2 RESTORE-1 trial is looking to enroll patients who have been diagnosed with Parkinson’s disease for at least four years, are not responding adequately to oral medications, and have a minimum of three hours of OFF time during the day as measured by a validated self-reported patient diary. Patients who meet the eligibility criteria will be randomized (1:1) to one-time administration of VY-AADC (for a total dose of up to 2.5×1012 vector genomes) or placebo surgery.
MRI Interventions, Inc. (MRIC), closed Wednesday's trading session at $3.24, up 2.86%, on 11,609 volume with 21 trades. The average volume for the last 3 months is 9,224 and the stock's 52-week low/high is $1.33/$3.737.
Teranga Gold Corporation (TGCDF)
The Street, Stockhouse, OTC Markets, 4-Traders, Capital Equity Review, Simply Wall St, Street Insider, InvestorsHub, The Northern Miner, 24hgold, Canadian Insider, Junior Mining Network, GuruFocus, YCharts, Investcom, and MarketWatch reported beforehand on Teranga Gold Corporation (TGCDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Teranga Gold Corporation is a multi-jurisdictional West African gold company listed on the OTCQX. Its emphasis is on production and development and the exploration of more than 6,400 km2 of land located on prospective gold belts. The Company is advancing its Wahgnion Gold Project, with an earlier released positive Feasibility Study (FS), and conducting extensive exploration programs in Burkina Faso, Senegal and Côte d’Ivoire. Teranga Gold is based in Toronto, Ontario.
The Company has close to 4.0 million ounces of gold reserves from its combined Sabodala Gold operations and Wahgnion Gold Project. Since its initial public offering (IPO) in 2010, Teranga Gold has produced greater than 1.4 million ounces of gold from its operations in Senegal, which as of June 30, 2017, had a reserve base of 2.7 million ounces of gold.
Teranga Gold owns and operates the Sabodala Gold mine, which is the only gold mine and mill in Senegal, West Africa. This mine is roughly 650 km southeast of Dakar, the capital of Senegal. Sabodala has been in operation since 2009. The Sabodala Mining Concession and the surrounding exploration permits are positioned within the highly prospective Kedougou-Kenieba Inlier that forms part of the Paleoproterozoic age Birimian Terrane of the West African Craton.
In October of 2016, the Banfora Gold Project was acquired as part of Teranga Gold’s acquisition of Gryphon Minerals. The fully permitted, high-grade, open pit Banfora Gold Project is in the southwest of Burkina Faso, West Africa. It is in a major gold producing district host to a number of first-rate gold deposits. Teranga Gold owns 90 percent of the Project. The Burkina Faso government owns the remaining 10 percent.
Teranga Gold has acquired the remaining 49 percent interest in the Golden Hill and Gourma projects from Boss Resources Limited. Teranga previously had the right to increase its 51 percent stake and earn up to an 80 percent interest in each project upon delivery of an FS on either project and the payment of AUD2.5 million. With the transaction, Teranga Gold owns a 100 percent interest in each of the Golden Hill and Gourma projects in Burkina Faso, West Africa.
Last week, Teranga Gold announced an initial mineral resource estimate for its Golden Hill advanced exploration project, situated within the central part of the highly mineralized Houndé Greenstone Belt in southwest Burkina Faso, West Africa. Golden Hill resource estimate highlights include Indicated mineral resources of 6.40Mt averaging 2.02 g/t gold for 415,000 ounces. Highlights also include Inferred mineral resources of 11.95Mt averaging 1.68 g/t gold for 644,000 ounces. There is excellent along trend and to-depth continuity of gold mineralization at all prospects drilled.
Additionally, last week, Teranga Gold reported its operating and financial results for the three and twelve months ended December 31, 2018. The Company also provided an update on the development of its second mine, Wahgnion Gold Operations. Operating highlights include record full-year gold production of 245,230 ounces, surpassing the high end of the Company’s increased 2018 production guidance range of 235,000-240,000 ounces.
Wahgnion Gold Operations achieved significant construction project milestones in 2018. It is on track for first gold pour and ramp up to nameplate production in Q4 2019. It increased open-pit mineral reserves by approximately 40 percent to 1.6 million ounces. Moreover, Wahgnion increased mine life to 13 years and improved first five years’ production and cost profile.
Teranga Gold Corporation (TGCDF), closed Wednesday's trading session at $2.78, up 1.15%, on 40,600 volume with 77 trades. The average volume for the last 3 months is 26,250 and the stock's 52-week low/high is $2.40/$4.32.
Organigram Holdings, Inc. (OGRMF)
Penny Stock Tweets, Daily Marijuana Observer, TradingView, Microcap Daily, The Street, Wallet Investor, Marijuana Stock, Marijuana Stocks Report, CFN Media Group, InvestorPlace, Wealth Daily, Cannabis Financial Network News and Money Morning reported previously on Organigram Holdings, Inc. (OGRMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Organigram Holdings, Inc.’s focus is on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada. The Company’s wholly-owned subsidiary, Organigram, Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram has developed a portfolio of brands. These include The Edison Cannabis Company, Ankr Organics, Trailblazer and Trailer Park Buds. Organigram’s head office, production facility, and Research and Development (R&D) are in Moncton, New Brunswick.
Organigram provides a varied array of genetics and product types. These cater to the individual needs of each client. The Company offers a reliable supply of premier quality, industry-leading strains to match individuals’ personal needs. The Company has collaborations with healthcare experts and academic institutions. It invests in medical education, outreach, and also research for the use of cannabinoids as a first line of treatment.
Organigram is undergoing a production-facility expansion. The expansion will more than triple the size of its operations. The multi-million-dollar project will meet the increasing needs of its medical patient base, and prepare it for the legal, adult-recreational marijuana market.
The Company’s plans also include a production-capacity increase from about 5,200 kilograms (kg) per year to more than 25,000 kg per year. Plans additionally include the acquisition of a third building at 55 English Drive for future expansion, next to the current campus.
Organigram Holdings and Eviana Health Corporation jointly announced this past June that they entered into a non-binding term sheet. Organigram will make a significant equity investment into Eviana. The Term Sheet also contemplates Organigram entering into an offtake agreement with Eviana for up to 50 percent of the cannabidiol (CBD) production of Eviana for a period of five years. This is subject to adjustment based on Organigram’s equity interest in Eviana.
Last month, Organigram Holdings announced that it, via its wholly-owned subsidiary 10870277 Canada, Inc. (OGI), executed an investment agreement dated as of October 10, 2018 with alpha-cannabis® Pharma GmbH (ACG) wherein the Purchaser will acquire 8,333 common shares of ACG, representing a 25 percent stake in the capital of ACG, for aggregate proceeds of €1,625,000.
Mr. Greg Engel, Organigram Chief Executive Officer, said, "As we continue to build the framework of our international medical business, finding the right partners in the right markets has been a priority for our company. This relationship is a perfect example of two companies coming together towards a common goal, and we're very excited to build our business in Germany through our partners at alpha-cannabis® Pharma GmbH."
Organigram Holdings announced recently that it signed a supply agreement with the Province of British Columbia. The Company signed an agreement with the BC Liquor Distribution Branch (BCLDB), the sole, wholesale distributor of non-medical cannabis for the Province, which will operate standalone, public retail stores and provide online sales. To date, Organigram has secured cannabis distribution agreements in eight of ten provinces.
Organigram Holdings, Inc. (OGRMF), closed Wednesday's trading session at $7.397, up 1.33%, on 983,001 volume with 2,185 trades. The average volume for the last 3 months is 864,958 and the stock's 52-week low/high is $2.569/$7.469.
CanAlaska Uranium Ltd. (CVVUF)
Equity Clock, Dividend Investor, Morningstar, Stockhouse, Streetwise Reports, OTC Markets Group, InvestorsHub, Resource World, last10k, FeedBlitz, GuruFocus, Wallet Investor, and MarketWatch reported earlier on CanAlaska Uranium Ltd. (CVVUF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
CanAlaska Uranium Ltd. is an exploration stage enterprise listed on the OTCQB. The Company focuses on two important projects in the Athabasca Basin in the Province of Saskatchewan. It holds interests in about 102,870 hectares (254,000 acres), one of the largest land positions in Canada's Athabasca Basin region. A project generator, CanAlaska Uranium has its head office in Vancouver, British Columbia.
The Company’s strategic holdings have attracted major international mining companies. Currently, CanAlaska Uranium is working with Cameco and Denison at two of CanAlaska’s properties in the Eastern Athabasca Basin.
CanAlaska’s projects include Cree East, West McArthur, NW Manitoba, and base metals and gold projects and other uranium projects as well as its diamond projects. The Cree East project is a high-priority property situated in the southeastern portion of the Athabasca Basin.
The West McArthur project is adjoining the world’s richest uranium mine -Cameco's McArthur River. The objective at West McArthur is a large unconformity uranium deposit. Moreover, $20 million of work successfully identified seven target areas. The NW Manitoba project lies in northwest Manitoba just east of the border of northeast Saskatchewan. It is 70 kilometers north of Reindeer Lake.
CanAlaska acquired four new claims groups in the western Athabasca Basin for diamond exploration. Three of these are in the region just north of current claims in the Patterson Lake area.
The Company has new targets developed at the Thompson Nickel Belt Properties. In Manitoba, CanAlaska has continued Project Generation activities, with licence acquisitions in the Thompson Nickel Belt. Compilation work has continued. More targets have been developed on the Strong and Hunter properties.
Last month, CanAlaska Uranium reported that plans have been made for drill testing of the northern portion of Grid 5, where Cameco identified multiple intercepts of uranium mineralization in the most recent drill programs. Under the Joint Venture (JV) with Cameco, CanAlaska Uranium will act as Operator and plans to drill 7000 meters in 10 drill holes in summer 2019 to endeavor to intersect lenses of higher-grade uranium mineralization.
Last week, CanAlaska Uranium reported on successful completion of drilling at Manibridge, Manitoba. Four holes showed semi-massive and massive sulphide mineralization with associated wider zones of disseminated sulphides near existing mineralization. The four hole, 1,000 meter drill program successfully intercepted a wide fold structure, 2.5 kilometers north of the past-producing high-grade Manibridge nickel mine.
Nickel mineralization was intersected in all holes. In each case a zone of massive sulphides, 0.5 to 4 meters long in drill holes, is hosted by a wide zone of disseminated sulphide mineralization (8 to 14 meters in length).
CanAlaska Uranium Ltd. (CVVUF), closed Wednesday's trading session at $0.2082, up 2.28%, on 1,255 volume with 2 trades. The average volume for the last 3 months is 12,901 and the stock's 52-week low/high is $0.187/$0.3455.
The QualityStocks Company Corner
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Earth Science Tech, Inc. (ETST)
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
- ChineseInvestors.com (CIIX)
- Sharing Services Global Corporation (SHRV)
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)
- Youngevity International, Inc. (NASDAQ: YGYI)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Green Hygienics Holdings Inc. (GRYN)
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)
- Sugarmade, Inc. (SGMD)
- Golden Developing Solutions, Inc. (DVLP)
- Cannabis Strategic Ventures, Inc. (NUGS)
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is expanding its CBD+ Wellness line with Pure and Pure Plus tinctures. Wildflower also recently announced that it is planning further additions to its CBD+ product line (http://nnw.fm/nRt7W). NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://nnw.fm/WLDFF.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.6181, up 10.97%, on 14,302 volume with 25 trades. The average volume for the last 3 months is 14,926 and the stock's 52-week low/high is $0.009/$1.139.
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Adds Pure, Pure Plus Tinctures to CBD+ Wellness Line, Plans Expansion
- Wildflower Brands and HelloMD to Expand Business Together
- Wildflower Featured in NetworkNewsWire Publication Discussing Opportunity in the CBD Rush
Earth Science Tech, Inc. (ETST)
Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is expanding its full-spectrum CBD product distribution to wider markets, including pharmacies. Cowen & Co. research finds that independent pharmacies like the high margins and differentiation from larger chains offered by CBD oils (http://nnw.fm/fD89D). Also today, NetworkNewsWire released a report on the company detailing how ETST is expanding its market reach through distribution agreements that will make the company’s full-spectrum CBD available to additional dispensaries and health care practitioners. To view the full article, visit: http://nnw.fm/tU9ie.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.615, up 0.82%, on 4,820 volume with 10 trades. The average volume for the last 3 months is 32,422 and the stock's 52-week low/high is $0.421/$2.45.
- Earth Science Tech Inc.’s (ETST) Strategy of Targeting Pharmacies for Cannabidiol Products Dovetails with Analysis of CBD Market
- NetworkNewsBreaks – Earth Science Tech Inc. (ETST) Expands Distribution into Larger Markets
- NetworkNewsBreaks – Earth Science Tech Inc. (ETST) Consultant Is Perfect Fit to Improve Shareholder Communication, Progress on CSE Listing
Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) was highlighted today in a publication from Investorideas.com, which is the first of a two part series focusing on the Canadian cannabis landscape as companies prepare to have stores open and products available for April 20th (aka 420); the preeminent cannabis celebration. Also today, CHOOF was featured today in the 420 with CNW by CannabisNewsWire.
Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.
Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.
True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.
Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.
A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.
While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.
Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.5116, up 2.44%, on 480,063 volume with 249 trades. The average volume for the last 3 months is 595,456 and the stock's 52-week low/high is $0.285/$1.129.
- Canada Prepares for 420: Canadian Cannabis Companies Open Their Doors for April
- 420 with CNW – Ontario Marijuana Stores Open as Fines Loom
- NetworkNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Enters MOU with Better Choice Company for Exclusive Distribution Rights to CBD Animal Health Products
ChineseInvestors.com (CIIX) was featured today in the 420 with CNW by CannabisNewsWire. When recreational marijuana was legalized across Canada on October 17, 2018, Ontario decided to start by only availing cannabis through a website run by the provincial government. Brick-and-mortar stores were slated to open in April this year, and yesterday (April 1) was the first day of storefront sales.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed the day's trading session at $0.50, even for the day, on 43,900 volume with 49 trades. The average volume for the last 3 months is 79,983 and the stock's 52-week low/high is $0.365/$1.25.
- 420 with CNW – Ontario Marijuana Stores Open as Fines Loom
- ChineseInvestors.com Inc. (CIIX) Subsidiary Launches High-End, Full-Spectrum Luxury Brand CBD Oil
- ChineseInvestors.com, Inc.’s Wholly Foreign-Owned Enterprise CBD Biotechnology Co. Ltd. Participates in the 29th Vietnam Expo 2019 to Develop New Markets for its Industrial Hemp Product Line
Sharing Services Global Corporation (SHRV)
Sharing Services Global Corporation (OTCQB: SHRV), formerly known as Sharing Services Inc., has seen a record-breaking pace of growth. Success is credited to SHRV’s Elepreneurs and their ability to execute the company’s mission, which is to change the direct-selling industry with best in-class products and services. Elepreneurs are independent contractors who share Elevacity products and invite others to join them on the Elepreneur team. Since its product launches of December 2017, the company has reported sales revenues of more than $64 million (http://nnw.fm/d8VdV). Operating under two divisions, Elevacity Global LLC and Elepreneur LLC, SHRV owns significant stakes in a variety of companies within the direct-selling industry.
Sharing Services Global Corporation (SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRV), closed the day's trading session at $0.22, even for the day, on 6,548 volume with 6 trades. The average volume for the last 3 months is 45,883 and the stock's 52-week low/high is $0.17/$0.449.
- Sharing Services Global Corporation (SHRV) Makes Strategic Moves toward International Expansion
- NetworkNewsBreaks – Sharing Services Global Corporation’s (SHRV) Elepreneur Subsidiary Founder Featured in ‘Networking Times’
- Sharing Services Global Corporation (SHRV) Subsidiary, Elepreneur, LLC., and its Founder Featured in ‘Networking Times’
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Canadian cannabis cultivation firm, recently announced that it would be hiring Canadian chef Ryan Reed to assist in the development of signature edible cannabis products. The company plans to launch the gourmet edible cannabis products in the last quarter of 2019. To view the full article, visit: http://nnw.fm/h0cjP.
The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.
Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.
Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.
Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.
In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.
Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.
Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:
- FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
- Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
- Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.
Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.
Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.
The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $5.95, off by 1.00%, on 135,692 volume with 215 trades. The average volume for the last 3 months is 263,014 and the stock's 52-week low/high is $2.74/$8.42.
- NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Hires Renowned Chef to Develop Edible Cannabis Products
- NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) to Host Q4 2018 Conference Call and Webcast
- The Flowr Corporation’s (TSX.V: FLWR) (OTC: FLWPF) Medical Cannabis Products are Now Available on Shoppers Drug Mart’s Online Store
Youngevity International, Inc. (NASDAQ: YGYI)
Youngevity International, Inc. (NASDAQ: YGYI) was featured today in a report by CannabisNewsWire. The U.S. Farm Bill that recently passed into law is a game-changer for the CBD space. While it is unknown when nationwide cannabis legalization may occur, incredible opportunities exist right now for CBD-focused companies that can deliver products to the marketplace.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $5.80, off by 0.17%, on 118,208 volume with 1,418 trades. The average volume for the last 3 months is 217,901 and the stock's 52-week low/high is $3.167/$16.25.
- CBD Industry Set to Explode as New Products, Consumers Enter Market
- YGYI's Khrysos Industries, Inks $11 Million Supply Contract for Sale and Processing of CBD Isolate Powder
- As Cannabidiol-Infused Beverage Market Grows, Youngevity International Inc. (NASDAQ: YGYI) Launches Two Relevant Products
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is moving quickly to take advantage of Canada’s nascent legal cannabis market, which is expected to include CBD-infused products by October 2019. TGOD’s recently announced entry into a multiyear extraction services contract with Valens GroWorks Corp. (CSE: VGW) (OTCQB: VGWCF) underscores the company’s focus on meeting a growing need to furnish high-quality, premium organic cannabis products to Canadian consumers, according to a news release (http://nnw.fm/MnI90).
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.3768, off by 4.34%, on 1,062,061 volume with 1,429 trades. The average volume for the last 3 months is 1,402,233 and the stock's 52-week low/high is $1.607/$7.894.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Partners with Valens GroWorks, Anticipates Early Market Entry
- The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) Receives Second Organic Certification; Gains Initial Approval on Hamilton Facility
- 420 with CNW – Colorado House Bill Could Make Marijuana Consumption Lounges Legal
Green Hygienics Holdings Inc. (GRYN)
Full-scope, premium-cannabis company Green Hygienics Holdings (OTCQB: GRYN) recently announced that it has opened escrow for the purchase of a ranch property near San Diego that consists of more than 824 acres of flat, native grassland pasture. To view the full article, visit: http://nnw.fm/jy3Jo.
Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.
The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.
Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.
Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.
Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.
The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.
Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.
Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.60, off by 2.34%, on 1,500 volume with 4 trades. The average volume for the last 3 months is 28,472 and the stock's 52-week low/high is $0.07/$0.722.
- NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Plans to Purchase Ranch as Potential Cultivation Site
- NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Eyeing Potential to Expand Yield Capabilities, Overall Market Presence
- Green Hygienics Holdings Inc. (GRYN) Eyes Lucrative Land Acquisition to Further Leadership Status in the Cannabis Industry
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
Petroteq Energy Inc. (TSXV: PQE; OTC: PQEFF; FSE: PQCF), a fully integrated oil and gas company, announces the closing and issuance of 15,000,000 common shares to Momentum Asset Partners I, LLC representing the equity component of the consideration payable by the Company pursuant to the acquisition from Momentum of 50% of the operating rights and interests relating to oil sands under U.S. federal oil and gas leases encompassing approximately 8,480 gross acres (4,240 net acres, less royalty) in the State of Utah.
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.
“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy Inc. (PHVAF), closed the day's trading session at $0.32, off by 3.00%, on 45,091 volume with 43 trades. The average volume for the last 3 months is 128,537 and the stock's 52-week low/high is $0.289/$1.43.
- Petroteq Energy Announces Closing of Resource Acquisition
- NetworkNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Achieves Significant Milestone in Continuous Production
- Petroteq Energy Announces Continuous Production
Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)
Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN), a Canadian iron ore exploration and development company, recently announced plans to complete a non-brokered private placement financing of up to 25 million units of the company at a price of $0.06 per unit. The proceeds from the offering will be used to advance the Black Iron Shymanivske project, according to a company press release (http://nnw.fm/mVj7I).
Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.
Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).
Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.
Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.
The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.
Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.
The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.
Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.
Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.
Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.
Black Iron Inc. (BKIRF), closed the day's trading session at $0.0612, off by 3.91%, on 18,350 volume with 10 trades. The average volume for the last 3 months is 49,263 and the stock's 52-week low/high is $0.0285/$0.0939.
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Seeks Private Placement Financing to Advance Shymanivske Project
- NetworkNewsBreaks – Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Closes First of Two Planned Tranches of Private Placement
- NetworkNewsBreaks – Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Eyeing 2019 as Pivotal for Company Development and Primary Shymanivske Project
Sugarmade, Inc. (SGMD)
A surge in hemp production means big business for hydroponic suppliers and Sugarmade Inc. (OTC: SGMD) (SGMD Profile) has strategically acquired several companies to meet demand and expand its foothold. The company was featured today in a report by CannabisNewsWire looking at the broader sector metrics.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.
Sugarmade, Inc. (SGMD), closed the day's trading session at $0.05, off by 1.67%, on 611,244 volume with 59 trades. The average volume for the last 3 months is 1,346,153 and the stock's 52-week low/high is $0.0425/$0.209.
- Hemp Market Drives Hydroponics Growth
- NetworkNewsBreaks – Sugarmade Inc. (SGMD) Strengthens Market Position via Planned Acquisition as Cultivation Supplies Shortages Rise
- Sugarmade Inc. (SGMD) Featured in CannabisNewsAudio Publication on Growing Role of Hydroponics
Golden Developing Solutions, Inc. (DVLP)
Golden Developing Solutions, Inc. (OTCMKTS: DVLP) (“DVLP” or the “Company”), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is very excited to announce the launch of its first annual 420 Shared Festival event. The Company has already successfully enlisted a critical mass of partners and will be working from the legendary "Mile High 420 Festival" in Denver, CO -- the largest free 420 festival in the world -- to connect a network of 420 cannabis festivals across the continent, creating a shared experience that will include broadcasts, prizes, and product samples.
Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.
Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.
DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.
DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.
WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.
“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”
The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.
“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”
Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.02, off by 23.08%, on 5,908,120 volume with 187 trades. The average volume for the last 3 months is 2,783,596 and the stock's 52-week low/high is $0.012/$0.14.
- DVLP to Host World's Largest 420 Festival with Launch of "Shared Festival" Event
- NetworkNewsBreaks – Golden Developing Solutions, Inc. (DVLP) Issues Shareholder Update and Steep Growth Potential Following Recent CBD Acquisition
- NetworkNewsBreaks – Golden Developing Solutions, Inc. (DVLP) Provides Shareholder Update
Cannabis Strategic Ventures, Inc. (NUGS)
Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.
The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.
Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.
Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.
Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.
Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.
Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.
The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.
Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.10, up 1.85%, on 11,963 volume with 35 trades. The average volume for the last 3 months is 117,341 and the stock's 52-week low/high is $1.02/$5.94.
- NetworkNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Cultivating Rich Portfolio to Grab Opportunity, Market Share
- NetworkNewsBreaks — Cannabis Strategic Ventures Inc. (NUGS) Developing Category Leaders within the Cannabis Sector
- 420 with CNW – Research Suggests You Could Be Storing Cannabis Improperly
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Closes First of Two Planned Tranches of Private Placement
- Cannabis Strategic Ventures, Inc. (NUGS) Cultivating Rich Portfolio to Grab Opportunity, Market Share
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Awarded Second Licence From Health Canada
- ChineseInvestors.com (CIIX) Subsidiary Launches High-End, Full-Spectrum Luxury Brand CBD Oil
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Enters MOU with Better Choice Company for Exclusive Distribution Rights to CBD Animal Health Products
- City View Green Holdings Inc. (CSE: CVGR) Partners with Leading Jamaican Blue Mountain Coffee Company
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Why Cool Events Is ‘One to Watch’
- Earth Science Tech, Inc. (ETST) Consultant Is Perfect Fit to Improve Shareholder Communication, Progress on CSE Listing
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Elects Globally Recognized Corporate and Political Strategist as Board Chairman
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Confirms Mineralization in 150-metre Step Out Hole and Announces Private Placement
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Receives Notice of Allowance for First Patent Application from U.S. Patent and Trademark Office
- Genprex Inc. (NASDAQ: GNPX) Posts Clinical, Corporate and Financial Update
- Global Consortium, Inc. (OTC: GCGX) is adding a Medical Grade Nutraceutical's Division
- Generation Alpha, Inc. (GNAL) 420 with CNW – New York City Legislators Consider Banning Pre-Employment Cannabis Tests
- Global Payout, Inc. (GOHE) and MTrac Expand to Deliver Solutions to Oregon and Hawaii Markets
- Golden Developing Solutions, Inc. (DVLP) Issues Shareholder Update and Steep Growth Potential Following Recent CBD Acquisition
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Five Stocks to Watch as Legal Marijuana Evolves
- Green Hygienics Holdings Inc. (GRYN) Eyeing Potential to Expand Yield Capabilities, Overall Market Presence
- Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) Bursting into US Energy Efficiency Market with Joint Venture, Acquisition Activity
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Launches Its Largest Cannabinoid Research Program
- Marijuana Company of America Inc. (MCOA) Latest Report Shows Quickly Increasing Number Of Consumers Using CBD Infused Products
- Medical Cannabis Payment Solutions (REFG) 420 with CNW – Utah Moves to Hire Software Provider for Medical Marijuana Program
- Millennial Lithium Corp. (TSX.V: ML) (FSE: A3N2) (OTCQX: MLNLF) Reports Positive Pumping Test Results from Third Production Scale Well at Pastos Grandes Project, Argentina; Investor Relations and Communications / Branding Agreements
- MustGrow Biologics Corp. is “One to Watch”
- Net Element, Inc. (NASDAQ: NETE) Subsidiary Offers Innovative POS Solutions to Restaurant Industry
- Nightfood, Inc. (OTCQB: NGTF) Announces Highest Revenue Quarter in Company History, National Roll-Out On Track as Ice Cream Secures Distribution in Fifteen States During Q1
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Provides Business Update
- Pacific Software, Inc. (PFSF) Recognized as One of the‘20 Most Promising AGTECH Solution Providers – 2019 by CIOReview
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) 5 Companies Prepared to Dominate U.S. Hemp-infused Beverages
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Achieves Significant Milestone in Continuous Production
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Jon Paul appointed as PLUS’ Chief Financial Officer, Craig Heimark takes on the role of Chief Strategy Officer
- Pressure BioSciences Inc. (PBIO) CBD-Infused Beverages Achieve Quality and Clarity Breakthrough Utilizing Pressure BioSciences' Ultra Shear Technology Platform
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Looks to Greatly Expand Irgon Lithium Mine Historic Resource
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) 420 with CNW – Michigan Commission Advises the State to Avoid Setting THC Impairment Limit for Drivers
- Sharing Services Global Corporation (SHRV) Elepreneur Subsidiary Founder Featured in ‘Networking Times’
- SinglePoint, Inc. (SING) Featured in NetworkNewsAudio Publication on Role of Data in Automotive Sector
- Spectrum Global Solutions, Inc. (SGSI) Posts Q4, Full Year 2018 Financial Results
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Receives Processing License from Health Canada
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Announces Closing of $11.4 Million Bought Deal Including Partial Exercise of Over-Allotment Option
- Sugarmade, Inc. (SGMD) Strengthens Market Position via Planned Acquisition as Cultivation Supplies Shortages Rise
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expands 7ACRES Cannabis Growing Space
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) to Host Q4 2018 Conference Call and Webcast
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Receives Second Organic Certification; Gains Initial Approval on Hamilton Facility
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Set to Thrive within Blossoming Cosmeceutical Industry
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Provides Clarifying Information in Respect of Third Party Business Valuation for Facility Acquisition
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Subsidiary Receives Health Canada Approval for Vanluven Road Facility Expansion
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and HelloMD to Expand Business Together
- Youngevity International, Inc. (NASDAQ: YGYI) Khrysos Industries, Inks $11 Million Supply Contract for Sale and Processing of CBD Isolate Powder
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.